Neonatal screening for congenital adrenal hyperplasia using 17-hydroxyprogesterone assay in filter paper blood spots

Hormone Research in Paediatrics

Volumn 30, Issue 6, 1988, Pages 235-240

  Larsson, Agne ^a,b   Hagenfeldt, Lars ^a,c   von Döbeln, Ulrika ^a,d   Curstedt, Tore ^c   Gustafsson, Jan ^b   Svensson, Elisabeth ^c  

^a National Bacteriological Laboratory   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d ST GÖRAN S HOSPITAL   (Sweden)

Author keywords

17 hydroxyprogesterone; Congenital adrenal hyperplasia; Neonatal screening

Indexed keywords

HYDROXYPROGESTERONE;

ADRENAL HYPERPLASIA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; METHODOLOGY; NEWBORN; PRIORITY JOURNAL;

17-HYDROXYPROGESTERONE; ADRENAL HYPERPLASIA, CONGENITAL; BIOLOGICAL MARKERS; FEMALE; GESTATIONAL AGE; HUMAN; HYDROXYPROGESTERONES; INFANT, NEWBORN; INFANT, PREMATURE; MALE; MASS SCREENING; PAPER; RADIOIMMUNOASSAY; REFERENCE VALUES; SUPPORT, NON-U.S. GOV'T;

EID: 0024214381     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000181069     Document Type: Article

References (12)

1. Lebovitz RM, Pauli RM, Laxova R: Delayed diagnosis in congenital adrenal hyperplasia. Need for newborn screening. Am J Dis Child 1984;138:571–573.
2. Hughes IA, Riad-Fahmy D, Griffiths K: Plasma 17-OH-proges-terone concentrations in newborn infants. Arch Dis Childh 1979;54:347–349.
3. Pang S. Hotchkiss J. Drash AL, et al: Microfilter paper method of 17a-hydroxyprogesteronc radioimmunoassay: Its application for rapid screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab 1977;45:1003–1008.
4. Pang S, Murphy W, Levine LS, et al: A pilot newborn screening for congenital adrenal hyperplasia in Alaska. J Clin Endocrinol Mctab 1982:55:413–420.
5. Piazzi S, Capelli M, Paolini M, et al: Neonatal screening for 21-hydroxylase deficiency: a microfilter paper method for 17-a-hydroxyprogesterone assay. J Endocrinol Invest 1982;5:87–90.
6. Wallace AM, Beastall GH, Cook B, et al: Neonatal screening for congenital adrenal hyperplasia: A programme based on a novel direct radioimmunoassay for 17-hydroxyprogesterone in blood spots. J Endocrinol 1986:108:299–308.
7. Shimozawa K, Saisho S, Saito N, et al: A neonatal mass-screening for congenital adrenal hyperplasia in Japan. Acta Endocrinol 1984;107:513–518.
8. Aim J, Larsson A: Evaluation of a nationwide neonatal metabolic screening program in Sweden 1965-1979. Acta Paediatr Scand 1981;70:601–607.
9. Axclson M, Sahlberg BL, Sjòvall J: Analysis of profiles of conjugated steroid in urine by ion-exchange separation and gas chro-matography/mass spectrometry. J Chromatogr 1981;224:355–362.
10. Werder EA, Siebenmann RE, Knorr-Murset G, et al: The incidence of congenital adrenal hyperplasia in Switzerland - a survey of patients bom 1960 to 1974. Helv Paediatr Acta 1980:35: 5–11.
11. Cacciari E, Balsamo A, Cassio A, et al: Neonatal screening for congenital adrenal hyperplasia using a microfilter paper method for 17a-hydroxyprogesterone radioimmunoassay. Horm Res 1982;16:4–9.
12. Farriaux JP, Dhondt JL, Dorche C, et al: Dépistage néonatal de l’hyperplasie congénitale des surrénales par déficit en 21-hydroxylase. Réalités et perspectives. Arch Fr Pédiatr 1987;44: 739–747.